EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report) was the target of a significant growth in short interest in the month of January. As of January 15th, there was short interest totaling 10,575 shares, a growth of 46.1% from the December 31st total of 7,240 shares. Based on an average trading volume of 198,536 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the company’s stock are sold short. Currently, 0.0% of the company’s stock are sold short. Based on an average trading volume of 198,536 shares, the days-to-cover ratio is currently 0.1 days.
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on ESLOY. HSBC raised shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a research note on Wednesday, January 14th. UBS Group upgraded shares of EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a research note on Thursday, November 27th. The Goldman Sachs Group restated a “buy” rating on shares of EssilorLuxottica in a research report on Friday, December 5th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of EssilorLuxottica in a report on Tuesday, October 28th. Finally, Kepler Capital Markets raised EssilorLuxottica from a “hold” rating to a “buy” rating in a research note on Thursday, January 15th. Two research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy”.
View Our Latest Analysis on EssilorLuxottica
EssilorLuxottica Stock Performance
EssilorLuxottica Company Profile
EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.
The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.
Featured Stories
- Five stocks we like better than EssilorLuxottica
- The day the gold market broke
- Forget AI, This Will Be the Next Big Tech Breakthrough
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Gold’s getting scarce.
- End of America Update
Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.
